Updated on 30 October 2013
"It is worthwhile mentioning that PABP is designed to be implanted in patients with heart failure prior to irreversible stage to hopefully restore heart function," according to Dr Lu.
However, the most important part would be the minimally invasive surgery, which allows rapid implantation into the aorta without affecting heart functions, thus shortening the recovery time after surgery.
Last year, Dr Lu's research team had signed a three-year agreement with the Division of Cadiothoracic Surgery, Department of Surgery at Duke University on the R&D of cardiac assist device, efficacy and safety regarding surgical treatment on patients with heart failure and the pathway of cell recovery after long-term PABP support.
"NCKU's PABP research outcome can be applied on patients with heart failure of non-refractory stage," noted Dr Daneshmand, who was impressed by NCKU's latest medical invention. He also added, "It can also be used to restore heart function of patients with late stage heart failure and prolong patient's life with reasonable quality; hence it is a very advanced piece of medical innovation."